WHO ICTRP trial
A phase III study of primary chemotherapy in T2 (G3), T3 and T4a; N0 or NX; M0…
ISRCTN82694463 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN82694463 |
|---|---|
| Public title | A phase III study of primary chemotherapy in T2 (G3), T3 and T4a; N0 or NX; M0 transitional cell carcinoma (TCC) of the bladder |
| Primary sponsor | Medical Research Council (MRC) (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | United Kingdom |
| Conditions | Bladder cancer Cancer Transitional cell carcinoma (TCC) of the bladder |
| Interventions | Primary chemotherapy in T2 (G3), T3 and T4a; N0 or NX; M0 TCC of the bladder |
| Registration date | Mar 13, 2001 |
| Target size | 975 |
| Secondary IDs | BA06 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: